US Patent Issued to Vertero Therapeutics on Oct. 27 for "Inhibitors of microbially induced amyloid" (Massachusetts, Connecticut Inventors)

ALEXANDRIA, Va., Oct. 27 -- United States Patent no. 12,774,290, issued on Oct. 27, was assigned to Vertero Therapeutics Inc. (Woburn, Mass.).

"Inhibitors of microbially induced amyloid" was invented by Anthony Stewart Campbell (Framingham, Mass.), Christopher J. Oalmann (Watertown, Mass.), Dennis S. Yamashita (Cambridge, Mass.) and Alessandra Bartolozzi (Norwalk, Conn.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure provides compounds useful for the prevention of amyloid formation and the treatment of amyloid related disorders, including synucleopathies such as Parkinson's Disease."

The patent was filed on Jan. 8, 2021, under Application No. 17/791,760.

*For further information, incl...